at The Fairmont Chicago!
The Robert H. Lurie Comprehensive Cancer Center of Northwestern University hosts this symposium geared toward practitioners treating breast cancer patients. Informal interaction with national and international thought leaders is frequently cited as one of the highlights of this annual event held in downtown Chicago.
This 3.5 day event features over 30 speakers and 8 sessions:
- Supportive Care Issues in the Management of Breast Cancer
- Breast Pathology for the Non-Pathologist
- Challenging Clinical Cases
- Risk & Prevention
- Endocrine Therapy
- Metastatic Breast Cancer Issues
- Current Controversies in Breast Cancer Management
- Unresolved Issues
Visit the Lynn Sage Breast Cancer Symposium Website for details.
Who Should Attend
Surgical oncologists, surgeons, medical oncologists, radiation oncologists, oncology nurses and other healthcare professionals and scientists involved in the diagnosis, treatment and management of breast malignancies.
The Northwestern University Feinberg School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Credit Hour Statement
The Northwestern University Feinberg School of Medicine designates this live activity for a maximum of 22.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
At the conclusion of this symposium participants should be able to:
- Incorporate current guidelines and recent data on local therapies, including advances in surgical and radiation therapy, into the treatment of patients with breast cancer.
- Integrate biomarkers, molecular assays, and other risk assessment tools in treatment decision-making for breast cancer when appropriate.
- Review current standards and emerging data regarding systemic therapies for the treatment of early-stage, locally advanced, and metastatic breast cancer.
- Summarize the challenges and available options in treating triple negative breast cancer.
- Identify new agents for overcoming endocrine resistance.
- Identify the options for individualizing care in the breast cancer patient and the challenges associated with providing care and long term survivorship planning.
- Recognize the unique clinical and surgical decisions which need to be taken into consideration in younger and elderly patients diagnosed with breast cancer.
Thank you to the
Lynn Sage Cancer Research Foundation
for its ongoing support